Cargando…

Behçet uveitis: Current practice and future perspectives

Described as early as Hippocrates in his “Third Book of Endemic Diseases,” Behçet's Disease (BD), also known as “The Silk Road Disease” following its initial demographics, consists of a triad of recurrent oro-genital ulcers and associated uveitis. Current demographics and rising percentages of...

Descripción completa

Detalles Bibliográficos
Autores principales: Aboul Naga, Shereen H., Hassan, Lameece Moustafa, El Zanaty, Radwa T., Refaat, Mohammad, Amin, Rana H., Ragab, Gaafar, Soliman, Mahmoud M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490079/
https://www.ncbi.nlm.nih.gov/pubmed/36160151
http://dx.doi.org/10.3389/fmed.2022.968345
_version_ 1784793013475606528
author Aboul Naga, Shereen H.
Hassan, Lameece Moustafa
El Zanaty, Radwa T.
Refaat, Mohammad
Amin, Rana H.
Ragab, Gaafar
Soliman, Mahmoud M.
author_facet Aboul Naga, Shereen H.
Hassan, Lameece Moustafa
El Zanaty, Radwa T.
Refaat, Mohammad
Amin, Rana H.
Ragab, Gaafar
Soliman, Mahmoud M.
author_sort Aboul Naga, Shereen H.
collection PubMed
description Described as early as Hippocrates in his “Third Book of Endemic Diseases,” Behçet's Disease (BD), also known as “The Silk Road Disease” following its initial demographics, consists of a triad of recurrent oro-genital ulcers and associated uveitis. Current demographics and rising percentages of patients seen far beyond the Silk Road in Ocular Inflammatory Disease and Uveitis Clinics list BD uveitis as one of the frontliners of non-infectious autoinflammatory eye diseases. Clinical features of BD and juvenile-onset BD are detailed alongside various approaches in classification and suggested algorithms for diagnosis that are outlined in this review. With the ongoing Human Microbiome Project and studies such as the MAMBA study, the role of the human microbiome in BD is highlighted in the pathophysiology of BD to include the current research and literature perspective. Furthermore, with the advancement of recent diagnostic and investigative techniques, especially in the field of Optical Coherence Tomography (OCT), disease-related characteristics are updated to encompass SD, EDI and OCT-angiography characteristics of BD. Having entered the era of biologic therapy, the role of various specific cytokine-blocking biologic drugs, such as TNF-α inhibitors (e.g., adalimumab, infliximab), interferon α-2a inhibitors, IL-6 and IL-1 inhibitors are presented and contrasted alongside the conventional immunosuppressant drugs and the classic old gold standard: corticosteroids (systemic or local). Finally, with the ongoing SARS-CoV-2 pandemic, it was not possible to conclude the review without reviewing the latest evidence-based literature reporting BD morbidity in this era, the observed pattern and treatment recommendations as well as those related to reported post-vaccine complications and emergence of BD.
format Online
Article
Text
id pubmed-9490079
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94900792022-09-22 Behçet uveitis: Current practice and future perspectives Aboul Naga, Shereen H. Hassan, Lameece Moustafa El Zanaty, Radwa T. Refaat, Mohammad Amin, Rana H. Ragab, Gaafar Soliman, Mahmoud M. Front Med (Lausanne) Medicine Described as early as Hippocrates in his “Third Book of Endemic Diseases,” Behçet's Disease (BD), also known as “The Silk Road Disease” following its initial demographics, consists of a triad of recurrent oro-genital ulcers and associated uveitis. Current demographics and rising percentages of patients seen far beyond the Silk Road in Ocular Inflammatory Disease and Uveitis Clinics list BD uveitis as one of the frontliners of non-infectious autoinflammatory eye diseases. Clinical features of BD and juvenile-onset BD are detailed alongside various approaches in classification and suggested algorithms for diagnosis that are outlined in this review. With the ongoing Human Microbiome Project and studies such as the MAMBA study, the role of the human microbiome in BD is highlighted in the pathophysiology of BD to include the current research and literature perspective. Furthermore, with the advancement of recent diagnostic and investigative techniques, especially in the field of Optical Coherence Tomography (OCT), disease-related characteristics are updated to encompass SD, EDI and OCT-angiography characteristics of BD. Having entered the era of biologic therapy, the role of various specific cytokine-blocking biologic drugs, such as TNF-α inhibitors (e.g., adalimumab, infliximab), interferon α-2a inhibitors, IL-6 and IL-1 inhibitors are presented and contrasted alongside the conventional immunosuppressant drugs and the classic old gold standard: corticosteroids (systemic or local). Finally, with the ongoing SARS-CoV-2 pandemic, it was not possible to conclude the review without reviewing the latest evidence-based literature reporting BD morbidity in this era, the observed pattern and treatment recommendations as well as those related to reported post-vaccine complications and emergence of BD. Frontiers Media S.A. 2022-09-07 /pmc/articles/PMC9490079/ /pubmed/36160151 http://dx.doi.org/10.3389/fmed.2022.968345 Text en Copyright © 2022 Aboul Naga, Hassan, El Zanaty, Refaat, Amin, Ragab and Soliman. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Aboul Naga, Shereen H.
Hassan, Lameece Moustafa
El Zanaty, Radwa T.
Refaat, Mohammad
Amin, Rana H.
Ragab, Gaafar
Soliman, Mahmoud M.
Behçet uveitis: Current practice and future perspectives
title Behçet uveitis: Current practice and future perspectives
title_full Behçet uveitis: Current practice and future perspectives
title_fullStr Behçet uveitis: Current practice and future perspectives
title_full_unstemmed Behçet uveitis: Current practice and future perspectives
title_short Behçet uveitis: Current practice and future perspectives
title_sort behçet uveitis: current practice and future perspectives
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490079/
https://www.ncbi.nlm.nih.gov/pubmed/36160151
http://dx.doi.org/10.3389/fmed.2022.968345
work_keys_str_mv AT aboulnagashereenh behcetuveitiscurrentpracticeandfutureperspectives
AT hassanlameecemoustafa behcetuveitiscurrentpracticeandfutureperspectives
AT elzanatyradwat behcetuveitiscurrentpracticeandfutureperspectives
AT refaatmohammad behcetuveitiscurrentpracticeandfutureperspectives
AT aminranah behcetuveitiscurrentpracticeandfutureperspectives
AT ragabgaafar behcetuveitiscurrentpracticeandfutureperspectives
AT solimanmahmoudm behcetuveitiscurrentpracticeandfutureperspectives